Isavuconazonium Sulfate API is a pharmaceutical-grade water-soluble prodrug of Isavuconazole, a broad-spectrum triazole antifungal agent. It is indicated for the treatment of invasive aspergillosis and invasive mucormycosis, particularly in immunocompromised patients.
After administration, Isavuconazonium Sulfate is rapidly converted by plasma esterases into the active antifungal agent Isavuconazole, which inhibits 14α-demethylase (CYP51), an enzyme essential for ergosterol synthesis in fungal cell membranes. This disruption leads to impaired fungal cell membrane integrity and inhibition of fungal growth.
The API is suitable for both intravenous injectable and oral capsule formulations, offering flexibility in antifungal treatment.
Manufactured under WHO-GMP-certified facilities, our Isavuconazonium Sulfate API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, stability, and batch-to-batch consistency. Each batch undergoes stringent quality testing and is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Isavuconazonium Sulfate API is used in oral and injectable pharmaceutical formulations for the treatment of invasive aspergillosis and invasive mucormycosis.
It is rapidly converted into Isavuconazole, which inhibits fungal 14α-demethylase (CYP51), disrupting ergosterol synthesis and preventing fungal cell membrane formation.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Isavuconazonium Sulfate API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp